# Carnosine ameliorates dexamethasone-induced muscle atrophy with associated modulation of ubiquitin ligases and oxidative stress in C57BL/6J female mice

**Authors:** Md Mizanur Rahman, Anayt Ulla, Honomi Ogura, Haruka Tsuda, Takayuki Uchida, Tomoya Fukawa, Takeshi Nikawa

PMC · DOI: 10.1016/j.crphys.2025.100169 · 2025-10-14

## TL;DR

Carnosine helps prevent muscle loss caused by dexamethasone in mice by reducing harmful protein activity and oxidative stress.

## Contribution

This study shows carnosine can reduce dexamethasone-induced muscle atrophy by targeting ubiquitin ligases and oxidative stress.

## Key findings

- Carnosine mitigated dexamethasone-induced reductions in muscle mass and myofiber cross-sectional area.
- Carnosine suppressed the expression of atrophy-related ubiquitin ligases Atrogin-1, MuRF1, and Cbl-b.
- Carnosine reduced oxidative stress and preserved IRS-1 levels in dexamethasone-treated mice.

## Abstract

Muscle atrophy, characterized by a decline in muscle mass and function, has limited treatment options, highlighting the need for further research. In this study, we investigated the effect of carnosine, a dipeptide with well-established antioxidant properties, on dexamethasone (Dex)-induced muscle atrophy in female C57BL/6J mice. Dex (10 mg/kg body weight) reduced muscle weight, cross-sectional area (CSA), and myosin heavy chain (MyHC) protein expression, while elevating the expression of the muscle atrophy–related ubiquitin ligases Atrogin-1 and Muscle RING-finger protein-1 (MuRF1). Dex also increased oxidative stress, leading to upregulation of the oxidative stress–sensitive ubiquitin ligase Cbl-b and downregulation of IRS-1. Notably, a 21-day treatment with carnosine (300 mg/kg body weight) significantly mitigated Dex-induced reductions in muscle mass, myofiber CSA, and MyHC protein, while suppressing ubiquitin ligase expression and preserving IRS-1 levels. Carnosine likewise decreased oxidative stress and the associated Cbl-b upregulation. These findings suggest that carnosine is a promising therapeutic candidate for managing Dex-induced muscle atrophy.

•
Carnosine prevented dexamethasone-induced muscle atrophy by improving myofiber CSA in mice.
•
Carnosine effectively attenuated Dex-induced degradation of fast and slow MyHC proteins.
•
Carnosine suppressed muscle-atrophy–associated ubiquitin ligases.
•
Carnosine acts as a strong antioxidant and reduces oxidative stress.

Carnosine prevented dexamethasone-induced muscle atrophy by improving myofiber CSA in mice.

Carnosine effectively attenuated Dex-induced degradation of fast and slow MyHC proteins.

Carnosine suppressed muscle-atrophy–associated ubiquitin ligases.

Carnosine acts as a strong antioxidant and reduces oxidative stress.

## Linked entities

- **Genes:** Fbxo32 (F-box protein 32) [NCBI Gene 67731], TRIM63 (tripartite motif containing 63) [NCBI Gene 84676], CBLB (Cbl proto-oncogene B) [NCBI Gene 868], IRS1 (insulin receptor substrate 1) [NCBI Gene 3667], MYH6 (myosin heavy chain 6) [NCBI Gene 4624]
- **Proteins:** Fbxo32 (F-box protein 32), CBLB (Cbl proto-oncogene B), IRS1 (insulin receptor substrate 1)
- **Chemicals:** carnosine (PubChem CID 439224), dexamethasone (PubChem CID 5743)

## Full-text entities

- **Genes:** Fbxo32 (F-box protein 32) [NCBI Gene 67731] {aka 4833442G10Rik, ATROGIN1, Gm20361, MAFbx}, Trim63 (tripartite motif-containing 63) [NCBI Gene 433766] {aka MuRF1, RF1, Rnf28}, Cblb (Cbl proto-oncogene b) [NCBI Gene 208650] {aka Cbl-b}, Irs1 (insulin receptor substrate 1) [NCBI Gene 16367] {aka G972R, IRS-1}, Rnf123 (ring finger protein 123) [NCBI Gene 84585] {aka Kpc1}, Myhc (myosin heavy chain, cardiac muscle complex) [NCBI Gene 111671]
- **Diseases:** decline in muscle mass (MESH:C536030), Muscle atrophy (MESH:D009133)
- **Chemicals:** Dex (MESH:D003907), dipeptide (MESH:D004151)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12554801/full.md

---
Source: https://tomesphere.com/paper/PMC12554801